Related references
Note: Only part of the references are listed.Regulation of insulin sensitivity, insulin production, and pancreatic β cell survival by angiotensin-(1-7) in a rat model of streptozotocin-induced diabetes mellitus
Junhua He et al.
PEPTIDES (2015)
Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells
Min Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice
Mohamad Nasser et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study
Chia-Hsuin Chang et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3
Youde Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Link between insulin resistance and hypertension: What is the evidence from evolutionary biology?
Ming-Sheng Zhou et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment
Nasui Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats
Jianxin Lu et al.
CARDIOVASCULAR DIABETOLOGY (2013)
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
Patricia C. Underwood et al.
CURRENT HYPERTENSION REPORTS (2013)
Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance
Jeffrey S. Bonner et al.
DIABETES (2013)
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus
Stefan Kiechl et al.
NATURE MEDICINE (2013)
An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice
Shannon M. Reilly et al.
NATURE MEDICINE (2013)
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
Kelly Putnam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Diabetes and hypertension: the bad companions
Ele Ferrannini et al.
LANCET (2012)
Microvascular Dysfunction: A Potential Mechanism in the Pathogenesis of Obesity-associated Insulin Resistance and Hypertension
Michiel P. De Boer et al.
MICROCIRCULATION (2012)
Link between the renin-angiotensin system and insulin resistance: Implications for cardiovascular disease
Ming-Sheng Zhou et al.
VASCULAR MEDICINE (2012)
Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion
Katarzyna Stolarz-Skrzypek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice
William L. Holland et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation
Ming-Sheng Zhou et al.
JOURNAL OF HYPERTENSION (2010)
Salt, aldosterone, and insulin resistance: impact on the cardiovascular system
Guido Lastra et al.
NATURE REVIEWS CARDIOLOGY (2010)
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension
Ming-Sheng Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Role of aldosterone and angiotensin II in insulin resistance: an update
Guido Lastra-Lastra et al.
CLINICAL ENDOCRINOLOGY (2009)
Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study
Jing Chen et al.
LANCET (2009)
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle
Michael G. Clark
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
New regulators of NF-κB in inflammation
Sankar Ghosh et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Shawna A. Cooper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells
Yongzhong Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes:: Reversal by exercise training -: Reversal by exercise training
A Sriwijitkamol et al.
DIABETES (2006)
Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes
KY Chu et al.
DIABETES (2006)
Reduced NAD(P)H oxidase in low renin hypertension - Link among angiotensin II, atherogenesis, and blood pressure
MS Zhou et al.
HYPERTENSION (2006)
The metabolic syndrome: Role of skeletal muscle metabolism
Craig S. Stump et al.
ANNALS OF MEDICINE (2006)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials
H Abuissa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
IKK-β links inflammation to obesity-induced insulin resistance
MC Arkan et al.
NATURE MEDICINE (2005)
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats
A Nishiyama et al.
KIDNEY INTERNATIONAL (2004)
Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells
F Andreozzi et al.
CIRCULATION RESEARCH (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase
T Ogihara et al.
DIABETOLOGIA (2004)
Skeletal muscle RAS and exercise performance
A Jones et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II
MS Zhou et al.
HYPERTENSION (2003)